Recent years have witnessed notable progress in tailoring treatments for solid tumors using biomarkers. Nevertheless, identifying specific biomarkers for ...

The second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood ...

An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...

Dave Coulier’s wife, Melissa Bring, gave an update on his health after he shared his stage 3 non-Hodgkin lymphoma diagnosis in 2024 ...

Dave Coulier’s wife Melissa gave a health update on the ‘Full House’ star’s “difficult” chemotherapy treatment since he was ...

An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai, has made a major breakthrough in treating a ...

Adc Therapeutics SA (ADCT), a biotechnology firm specializing in the development of antibody-drug conjugates for cancer treatment, has seen its stock price touch a 52-week low, reaching $1.66. With a ...

What Happened: The latest Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission uncovered CAGNONI, ...

What Happened: A notable Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission revealed that Trotta, EVP at Incyte, exercised stock options for 0 shares of INCY, resulting in a ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Autolus Therapeutics (AUTL – Research ...